Stock TLN THALLION PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Thallion Pharmaceuticals Inc.

Equities

TLN

CA88327P1053

Biotechnology & Medical Research

Business Summary

Thallion Pharmaceuticals Inc is a Canada-based biotechnology company. The Company develops pharmaceutical products in the areas of infectious disease and oncology. Thallion Pharmaceuticals Inc's lead clinical program, Shigamabs, is a dual antibody product for the treatment of Shiga toxin-producing E. coli bacterial infections and has completed a Phase II clinical trial. The Company is a subsidiary of BELLUS Health.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,194,566 27,691,149 ( 86.01 %) 0 86.01 %

Company contact information

Thallion Pharmaceuticals, Inc.

1375 TransCanada Highway Suite 200

H9P 2W8, Dorval

+

http://thallion.com
address Thallion Pharmaceuticals Inc.(TLN)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.99% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.01% 106B
BIONTECH SE Stock BioNTech SE
-3.07% 24.69B
ARGENX SE Stock argenx SE
-0.93% 21.97B
GENMAB A/S Stock Genmab A/S
-5.71% 19.27B
BEIGENE, LTD. Stock BeiGene, Ltd.
-6.90% 17.56B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.36% 17.32B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.82% 14.03B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.05% 12.13B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. TLN Stock
  4. Company Thallion Pharmaceuticals Inc.